The IPO Buzz: Lightning in the IPO Sky
Lightning crackled in the IPO sky last week, driving the aftermarket performance of 2019’s IPOs into noteworthy territory. To get the story, all you have to do is look at the data on the IPOScoop.com website. (This week, biotech deals and Slack – a Direct Public Offering – dominate the IPO Calendar. We’ll get to those in a bit.) Look at the 2019 IPO Scorecard - June 16, 2019 on the lower ..
Read more June 16, 2019IPO Calendar
| Company | Symbol proposed | Shares (Millions) | Est. $ Volume | Expected to Trade | SCOOP Rating | Rating Change |
|---|---|---|---|---|---|---|
| Akero Therapeutics | AKRO | 5.8 | $ 92.0 mil | 6/20/2019 Priced | S/O | S/O |
| Atreca | BCEL | 7.4 | $ 125.0 mil | 6/20/2019 Priced | S/O | S/O |
| Dermavant Sciences Ltd. | DRMT | 7.7 | $ 100.1 mil | 6/20/2019 Postponed | S/O | S/O |
Last 100 IPOs - June 19, 2019
| Number of IPOs priced : | 100 |
| Number Up: | 58 |
| Number Down: | 42 |
| Number Unchanged: | 0 |
| Percentage Change From Issue Price: | 40.46% |
| Percentage Change for The Nasdaq Composite | -0.49% |
2019 IPO Scorecard - June 19, 2019
| Number of IPOs priced (Excluding 28 units) : | 67 |
| Number Up: | 41 |
| Number Down: | 26 |
| Number Unchanged: | 0 |
| Total Return From Issue Price: | 39.58% |
| The Nasdaq Composite Index YTD % Change | 20.80% |